Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment

[11] Bonini S(2004)Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis J Allergy Clin Immunol 114 851-91

[12] Burks AW(2013)Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy J Allergy Clin Immunol 132 353-1107.e2

[13] Calderon M(2015)Wirtschaftlichkeitsprüfung für SIT-Lösungen – Aufgepasst! Hier wird oft falsch gerechnet Allergo J 24 88-807

[14] Canonica W(2012)Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis-based comparison J Allergy Clin Immunol 130 1097-1345

[15] Cox L(2005)Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid Allergy 60 801-166.e3

[16] Demoly P(2007)Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis J Allergy Clin Immunol 120 1338-566

[17] Frew AJ(2009)Efficacy and safety of 5‑grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis J Allergy Clin Immunol 123 160-599

[18] O’Hehir R(2011)Sustained 3‑year efficacy of pre- and coseasonal 5‑grass-pollen sublingual immunotherapy ablets in patients with grass pollen-induced rhinoconjunctivitis J Allergy Clin Immunol 128 559-861

[19] Kleine-Tebbe J(2011)Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual Immunol Allergy Clin North Am 31 561-1481

[20] Muraro A(2015)Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany (Additional file 1 – Meta-analysis) Clin Transl Allergy 5 1-122

[11] Bonini S(2004)Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis J Allergy Clin Immunol 114 851-91

[12] Burks AW(2013)Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy J Allergy Clin Immunol 132 353-1107.e2

[13] Calderon M(2015)Wirtschaftlichkeitsprüfung für SIT-Lösungen – Aufgepasst! Hier wird oft falsch gerechnet Allergo J 24 88-807

[14] Canonica W(2012)Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis-based comparison J Allergy Clin Immunol 130 1097-1345

[15] Cox L(2005)Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid Allergy 60 801-166.e3

[16] Demoly P(2007)Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis J Allergy Clin Immunol 120 1338-566

[17] Frew AJ(2009)Efficacy and safety of 5‑grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis J Allergy Clin Immunol 123 160-599

[18] O’Hehir R(2011)Sustained 3‑year efficacy of pre- and coseasonal 5‑grass-pollen sublingual immunotherapy ablets in patients with grass pollen-induced rhinoconjunctivitis J Allergy Clin Immunol 128 559-861

[19] Kleine-Tebbe J(2011)Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual Immunol Allergy Clin North Am 31 561-1481

[20] Muraro A(2015)Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany (Additional file 1 – Meta-analysis) Clin Transl Allergy 5 1-122